Being overweight or obese is an important cause of rising cancer rates among younger adults in England, according to a major new study. Researchers at The Institute of Cancer Research, London, and ...

Since the discovery of X-rays in 1895, radiation therapy, or radiotherapy, has made substantial advancements as a cancer treatment. It’s now responsible for approximately 40 per cent of cancer cures.

The Government has today published the National Cancer Plan, setting out a 10-year strategy to improve cancer outcomes in England through new targets and measures to accelerate diagnosis and treatment ...

Scientists have created the most comprehensive map to date of the genetic mutations that fuel cancer – opening the door to extending precision treatments to thousands more patients and offering clues ...

In this feature, cancer scientists and animal research experts across The Institute of Cancer Research, London, discuss why breakthroughs gained by studying whole-body systems in animals are essential ...

A gene that is typically active only in reproductive cells may hold the key to new treatments for triple negative breast cancer, according to new research. Scientists from the Breast Cancer Now Toby ...

A new immunotherapy drug has shown promise for safely treating prostate cancer, a phase I trial reports. Almost half of the patients in the trial that could be evaluated saw their tumour shrink after ...

As we enter 2026, scientists at The Institute of Cancer Research, London, share the developments expected this year that could soon change how cancer is treated – from technologies designed to deliver ...

New research presents clear guidelines on how patient-reported outcomes (PROs) can be used more effectively in early-stage cancer drug trials, helping ensure that patient experiences meaningfully ...

A blood test can predict how well patients with advanced breast cancer will respond to targeted therapies – before treatment begins, according to new research. A team from The Institute of Cancer ...

The Institute of Cancer Research, London has welcomed the announcement by NHS England that the lifesaving drug abiraterone has been approved for use on the NHS for men in England with prostate cancer ...

Experts at The Institute of Cancer Research, London, have responded to the draft recommendation from the National Screening Committee (NSC) to implement a targeted prostate cancer screening programme ...